通过构建鸭乙肝病毒ε(Dε)的RNA文库并利用指数级富集的配体系统进化技术(SELEX)筛选的策略,获得与反转录酶(P蛋白)高度亲和的适配子(Aptamer),再通过体外引发实验和核酸酶切割方法测定全部适配子的RNA二级结构,以研究鸭乙型肝炎病毒(Duck Hepatitis B Virus,DHBV)中对启动P蛋白引发步骤至关重要的ε结构信息。本研究发现凡是支持P蛋白启动引发的高亲和力适配子中均包含完整的侧向突出结构;而一旦侧向突出被破坏,则适配子均不再支持P蛋白启动引发。本研究的结果表明Dε分子内部的一个完整侧向突出结构对于P蛋白启动引发是必不可少的。
In recent years,the in silico epitopes prediction tools have facilitated the progress of vaccines development significantly and many have been applied to predict epitopes in viruses successfully. Herein,a general overview of different tools currently available,including T cell and B cell epitopes prediction tools,is presented. And the principles of different prediction algorithms are reviewed briefly. Finally,several examples are present to illustrate the application of the prediction tools.
Hepatitis B virus (HBV), a typical member of the Hepadnaviridae family, is responsible for infections that cause B-type hepatitis which leads to severe public health problems around the world. The small enveloped DNA-containing virus replicates via reverse transcription, and this unique process is accomplished by the virally encoded reverse transcriptase (RT). This multi-functional protein plays a vital role in the viral life cycle. Here, we provide a summary of current knowledge regarding the structural characteristics and molecular mechanisms of HBV RT. Improved understanding of these processes is of both theoretical and practical significance for fundamental studies of HBV and drug discovery.
乙型肝炎病毒(hepatitis Bvirus,HBV)导致的慢性感染已经成为威胁全球健康的主要问题之一.传统的抗乙肝药物如以拉米夫定和阿德福韦为代表的核苷类似物以及干扰素类药物在临床上都存在一定的局限性,因此寻找新的抗乙肝药物已经成为当务之急.本文主要从小干扰RNA(small interfering RNA,siRNA)、微小RNA(microRNA,miRNA)和配体指数富集的系统进化技术(systematic evolution of ligands by exponential enrichment,SELEX)筛选的RNA适配子这3个方面来分别阐述用小分子RNA药物抗HBV的研究进展和展望.
乙型肝炎病毒(Hepatitis B virus,HBV)感染是诱发原发性肝癌的主要原因之一.HBV存在4个相互重叠的开放读码框:S,C,P和X区.其中X基因表达的蛋白HBx被认为是诱导肝癌发生的一种多功能致癌蛋白,它可以作用于众多信号通路及细胞因子从而诱发肝癌.本文根据最新的研究,选择其中p53和NF-κB两条信号通路及HBx与表观遗传修饰的相关性进行了探讨,目的在于部分揭示HBV感染诱发肝癌的发病机理.
